AST Products, Inc.
13
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Safety and Efficacy of the Bi-Aspheric Monofocal IOL
Role: collaborator
Visual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses
Role: lead
Comparative Clinical Study of Intraocular Lens Injectors Lioli™, Pioli™, and Pioli™ Plus
Role: lead
Clinical Performance of the Asqelio™ Trifocal Diffractive Intraocular Lens
Role: lead
Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design
Role: lead
PMCF Study of Preloaded Trifocal IOL
Role: collaborator
Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.
Role: lead
In-vivo Behavior of Asqelio Monofocal Biaspheric Intraocular Lens
Role: lead
Clinical Results of Asqelio™ EDOF Toric Soft Hydrophobic Intraocular Lens After Cataract Surgery
Role: lead
Clinical Results of Asqelio Trifocal Toric Diffractive Intraocular Lens
Role: lead
Clinical Evaluation of the Bioli IOL Delivery System (BIOLI-D)
Role: lead
Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens
Role: lead
Clinical Results of Asqelio Trifocal Diffractive Intraocular Lens
Role: lead
All 13 trials loaded